(Q38147092)

29 August 2017

1 reference

title

Fluid phase generation of terminal complement complex as a novel index of bioincompatibility (English)

1 reference

29 August 2017

Deppisch R

1

1 reference

29 August 2017

Schmitt V

2

1 reference

29 August 2017

Bommer J

3

1 reference

29 August 2017

Hänsch GM

4

1 reference

29 August 2017

Ritz E

5

1 reference

29 August 2017

Rauterberg EW

6

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 February 1990

1 reference

29 August 2017

1 reference

29 August 2017

37

1 reference

29 August 2017

696-706

1 reference

29 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1990.36

29 August 2017

0 references

cites work

Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Effects of complement activation by hemodialysis membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Leukocyte C5a receptor modulation during hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Neoantigens of the membrane attack complex of human complement

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Physicochemical characterization of fluid phase (SC5b-9) and membrane derived (MC5b-9) attack complexes of human complement purified by immunoadsorbent affinity chromatography or selective detergent extraction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Enzyme-Linked Immunosorbent Assay (ELISA) with Covalently Bound Protein on Glass Tubes: 1. Stable Antigenicity and Binding of IgG as a Model Antigen after Repeated Use

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Different in vitro generation of C3d by cuprammonium and polycarbonate capillary hemodialyzers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Biocompatibility of artificial organs: an overview

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Quantitation of activation of the human terminal complement pathway by ELISA

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

A simple immunoradiometric assay for the terminal SC5b-9 complex of human complement

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Increased plasma levels of the terminal complement complex in patients with evidence of complement activation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Generation and removal of anaphylatoxins during hemofiltration with five different membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Complement activation during hemodialysis: laboratory evaluation of hemodialyzers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Complement Activation During Hemodialysis: Clinical Observations, Proposed Mechanisms, and Theoretical Implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Early- and late-phase activation of complement evaluated by plasma levels of C3d,g and the terminal complement complex

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Ethylene oxide (ETO) as a major cause of anaphylactoid reactions in dialysis (a review).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Haemolytic 'efficiency' of C5b-9 complexes in drug-induced immune haemolysis: role of cellular C5b-9 distribution

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Thromboxane B2 synthesis in human platelets induced by the late complement components C5b-9

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Interleukin-1 activation and acute phase response during hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Blood-membrane interaction in hemodialysis leads to increased cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.36

7 January 2021

Identifiers

DOI

10.1038/KI.1990.36

1 reference

Dimensions Publication ID

29 August 2017

0 references

1 reference